SCM
Silverarc Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3M | Sell |
1,800,829
-259,411
| -13% | -$2.63M | 3.37% | 10 |
|
|
2025
Q1 | $11.5M | Buy |
2,060,240
+881,940
| +75% | +$4.92M | 2.35% | 15 |
|
|
2024
Q4 | $9.51M | Buy |
1,178,300
+78,810
| +7% | +$636K | 2.08% | 17 |
|
|
2024
Q3 | $11.3M | Buy |
1,099,490
+23,678
| +2% | +$243K | 2.53% | 13 |
|
|
2024
Q2 | $7.61M | Sell |
1,075,812
-37,195
| -3% | -$263K | 1.79% | 16 |
|
|
2024
Q1 | $15.3M | Sell |
1,113,007
-56,993
| -5% | -$784K | 4.25% | 4 |
|
|
2023
Q4 | $10.8M | Buy |
1,170,000
+46,655
| +4% | +$429K | 3.2% | 10 |
|
|
2023
Q3 | $6.8M | Sell |
1,123,345
-327,477
| -23% | -$1.98M | 2.06% | 14 |
|
|
2023
Q2 | $11.3M | Buy |
1,450,822
+14,877
| +1% | +$115K | 3.48% | 8 |
|
|
2023
Q1 | $8.18M | Buy |
1,435,945
+199,649
| +16% | +$1.14M | 3.38% | 5 |
|
|
2022
Q4 | $7.28M | Buy |
1,236,296
+27,304
| +2% | +$161K | 2.08% | 12 |
|
|
2022
Q3 | $3.87M | Buy |
1,208,992
+126,688
| +12% | +$405K | 1.31% | 23 |
|
|
2022
Q2 | $4.85M | Buy |
+1,082,304
| New | +$4.85M | 1.49% | 15 |
|